drugset / Trial / NCT05123651

Research on the Characteristics and Application of Lactobacillus Rhamnosus X253 as Oral Probiotics

NCT05123651 ↗

Completed 60 enrolled Junlebao Dairy Group Co., Ltd.
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The aim of the study is to study the application of Lactobacillus rhamnosus X253 as oral probiotics by the way of a randomised, double blinded, parallel, placebo-controlled clinical trial, and to eto detect the changes in oral flora of volunteers, and judge the improvement effect of X253 lozenges on the human oral flora.

Timeline

Start
2020-11-01
Primary completion
2021-02-14
Completion
2021-03-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus rhamnosus X253 Other / unclassified 0.8 g Oral

Indications